New biomarker test for heart disease risk; Brain structure may signal Alzheimer's

> Research indicates that a new test for a blood biomarker can be a better indicator of heart disease risk in the elderly than currently used methods. Story

> New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention. Release

> BioMarker Strategies says it was able to raise $2 million through Maryland's biotech investment tax strategy. The investments were made by a group of wealthy individuals. Article

> Germany's Epigenomics AG and Predictive Biosciences are extending their pact regarding a prostate cancer biomarker. Report

> Metabolon announced of "Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting" in PLoS ONE. Metabolon release

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.